Subgenomic RNAs for the expression of the three ORFs may start at these points. On all five tobraviral RNA2 molecules sequenced to date, these sequences were found upstream of the coat protein ORF in association with a strongly-conserved potential secondary structural element. Similar potential structures were identified upstream of other tobraviral ORFs. These structures may contribute to the activity of the tobraviral subgenomic promoter.
INTRODUCTION
The bipartite tobraviruses are among the majority of plant viruses in having a single-stranded, positive-sense RNA genome (1) . Their RNAs are capped at the 5' terminus and include a tRNAreminiscent 'pseudoknot' tertiary structure at the 3' terminus (2-4). The larger genomic RNA (RNA1) from different tobravirus strains is 6.8-7.0kb in length. Three distinct types of RNA 1 molecule have been identified on the basis of solution hybridization studies (5) (6) (7) . These correspond to three tobraviral subgroups, respectively containing isolates of tobacco rattle virus (TRV), pea early browning virus (PEBV) and pepper ringspot virus (PRV). The smaller genomic RNA (RNA2) from different tobravirus strains varies considerably in length between 1.8 and 3.9kb (8, 9) . Hybridization studies show that the RNA2 molecules within each subgroup are additionally variable in that they do not necessarily share extensively-homologous sequences (5) (6) (7) . On the basis of this variability, it has been suggested that tobraviral RNA2 molecules may not share a common evolutionary origin, even within the same subgroup (6) .
RNA1 can replicate and, to a variable extent, spread in plants in the absence of RNA2, but such infections produce none of the characteristic rod-shaped virus particles. These and similar studies suggested that RNA1 specifies functions concerned with replication and spread (10) (11) (12) . RNA2 specifies the coat protein in which both RNAs are independently-encapsidated (10 -12) . Since coat protein is similar in size for all tobraviral isolates at about 23K (13) , even the smallest of RNA2 molecules clearly has the theoretical capacity to encode further products. Nucleotide sequence data for RNA1 of TRV and PEBV isolates show that both include open reading frames for two large putative replicase proteins (the larger being produced by translational readthrough of the nonsense codon at which translation of the smaller is terminated), for a putative cell-to-cell spread product of 29K, and for a smaller product (12-16K) of unknown significance (14) (15) (16) (17) (18) (19) (20) . Nucleotide sequence data for RNA2 molecules from the PRV subgroup (8) and from the TRV subgroup isolates PSG (16) , PLB (21) and TCM (22) indicate that these RNAs are 1799 nucleotides, 1905 nucleotides, 2196 nucleotides and 3389 nucleotides long, respectively. Untypically for viral RNAs, no product is specified directly from the tobraviral RNA2 (23) . Instead, the coat protein each encodes by its 5'-proximal open reading frame is produced in vivo from a subgenomic RNA (RNA2a) which lacks most of the substantial ( > 500 nucleotides) RNA2 leader sequence (23) . The range of different RNA2 lengths is attributable in part to a 3' terminal RNA 1-homologous sequence which varies from 459 nucleotides (PRV) to 1099 nucleotides (TRV[TCM]) in length (8, 16, 21, 22) . These sequences are 100% homologous to the corresponding RNA1 sequence and, in the case of the TRV isolates TCM and PLB, include intact copies of the 3'-proximal RNA1 small open reading frame (21, 21) . The further length of the TRV(TCM) RNA2 reflects the presence of an additional open reading frame specifying a potential product of 29. IK (22) .
The complete nucleotide sequence of RNA2 from a representative member of the third tobraviral subgroup, that of the British PEBV isolate SP5, is presented here. The 3374 nucleotide sequence shows that, in addition to specifying coat protein and a potential product homologous to the 29. IK TRV(TCM) product, the RNA includes a unique open reading frame for a potential 23K product. In addition, novel features of tobraviral subgenomic promoters are identified.
MATERIALS AND METHODS
Virus purification and RNA extraction The SP5 isolate of PEBV (B) was obtained from M. A. Mayo (Scottish Crop Research Institute, Invergowrie) and propagated in Nicotiana clevelandii. Virus was extracted and purified by PEG/NaCl precipitation followed by two cycles of differential centrifugation (7) . After clarification with 1:1 chloroform:/ibutanol (24) , the S particles containing RNA2 were resolved from the L particles containing RNA1 by sucrose density gradient centrifugation (25) . Purified virus was treated with 5/ig/ml DNasel for 30 minutes before RNA extraction (9) . cDNA synthesis and cloning cDNA synthesis was primed with the ten residue deoxyoligonucleotide 5'GGGCGTAATA3' complementary to the 3' terminal sequence of RNAs 1 and 2 (26) . After synthesis and purification of the first strand (27) and of the second strand (28), double-stranded cDNAs were digested with either Sau3AI, TaqI or EcoRI, ligated into the appropriately-linearized M13mpl8 vector, and transformed into E. coli strain JM101 (29) . Recombinant plaques were identified and templates for sequencing prepared (29) . Double-stranded cDNAs were also prepared by the strand replacement method (30) using a commercial kit (Amersham) and the above primer. These cDNAs were digested with Bgin, ligated into BamHI/Smal-cut pBS(M13+)(Stratagene), and transformed into E. coli strain JM83 Rec A~. Recombinant carbenicillin-resistant colonies were selected for small scale preparation of plasmid (31) . These were characterized by restriction mapping and appropriate restriction fragments were subcloned into M13 vectors for sequencing.
Sequencing cDNA clones and RNA Sequence was determined from single-stranded M13 templates by the dideoxy chain termination method (32, 33) with the Klenow fragment of DNA poll (Pharmacia). Some longer sequences were determined using Sequenase (U.S.B.). Some subclones were generated from M13 replicative form DNAs by exoIH unidirectional deletion (34) .
The 5' terminal sequence of RNA2 was determined using the 28-residue, [ 32 P]-endlabelled deoxyoligonucleotide 5'AGCTC-AAAGTCATCTATCACACATCATG3' (complementary to nucleotides 4 2 -6 9 of RNA2) to prime dideoxy-terminated reverse transcription of the RNA (35) . Sequences upstream of the 3' terminus were similarly determined using the same ten residue deoxyoligonucleotide as was used to prime cDNA synthesis. Terminal transferase was used to extend nondideoxyterminated reaction products (36) .
Sequence assembly and analysis Sequence data were collated using the DB programs of Staden (37, 38) run on a microVAX 3600 computer. Dotmatrix comparisons were made using either DIAGON (38) or the programs of the University of Wisconsin package (39) . The program FASTA (40) was used to search computer databases. The statistical significance of similarities identified was assessed by Monte Carlo methods (RDF2; 40).
RESULTS

Sequence determination
The initially adopted approach to determining the sequence of PEBV(B)SP5 RNA2 was to sequence randomly-selected M13 clones containing inserts generated from PEBV RNA2-specific, double-stranded cDNA by digestion with Sau3AI or TaqI. Sequence corresponding to the central 65 % of the RNA was generated by these means. Many of the clones selected were reiterative, however, so use was subsequently made of EcoRI and Bglll sites revealed by this sequence to obtain larger clones. The cDNA sequence was completed from such clones, making use of specific restriction fragment subclones in M13 vectors. It was not possible, however, to obtain subclones from which the sequence between nucleotides 792 and 1133 (corresponding to a Dral-Haem fragment) could be obtained in the minus sense. This sequence was consequently determined by priming internally on two cDNA clones corresponding to RNA2 nucleotides 31-1724 and 31-1838, respectively, and using primers complementary to nucleotides 964-991 and 1142-1169 of RNA2. In total, all but the 5' 30 nucleotides were determined from cDNA clones. Each base was determined unambiguously on each strand at least twice, making use of at least two independently-isolated clones.
To determine the sequence of the 30 5' terminal nucleotides not represented by any cDNA clone, a deoxyoligonucleotide complementary to nucleotides 42-69 of the finally-derived RNA2 sequence was [ 32 P]-endlabelled and used to prime dideoxy-terminated reverse transcription reactions on RNA2. As noted previously for other capped RNAs (41), these sequences terminated with two intense bands (not shown). Use of terminal transferase to extend non-dideoxyterminated products (36) showed that no specific incorporation of a dideoxynucleotide complementary to the cap structure occurred (figure la).
A dideoxynucleotide complementary to the 3' terminal 10 residues of RNA2 (and, by virtue of the terminal homology between RNAs 1 and 2, to the corresponding residues of RNA1;23) was [ 32 P]-endlabelled and used to prime dideoxyterminated reverse transcription of mixed genomic RNAs 1 and 2. By using a mixture of both RNAs, it was hoped to obtain information about the length of the 3' terminal homology between the RNAs. The resulting sequence could, with the exception of that immediately adjacent to the primer, be read to a distance corresponding to 266 nucleotides from the termini of the RNAs (figure lb-d). Above mis point, bands are present in more than just one track in many positions (figure Id, above asterix). The resulting pattern is quite different from that of random, nonspecific termination products and apparently represents two different sequences contiguous with a common sequence below. Such a pattern would be expected had sequencing proceeded through the limit of terminal homology between the r 'RNAs. Comparison of the sequence with the subsequently determined RNA1 sequence confirmed that this was the case. Thus the 3' terminal homology between the RNAs of PEBV(B)SP5 is just 266 nucleotides in length. These comparisons also showed that nine consistently present ambiguities (indicated, figure 1 ) reflect sequence differences between the RNAs. and one encoding a potential product slightly less than 10K (ORF 4). A schematic representation of these ORFs is shown in figure  2 , with those of other sequenced tobraviral RNA2 molecules for comparative purposes.
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The first ORF starts with the seventh AUG from the 5' terminus at nucleotides 510-512 and extends to an UGA codon at nucleotides 1146-1148. This ORF encodes a potential product of 212 amino acid (AA) residues with a mol. wt. of 23,244 (23.2K). The position of this ORF downstream of a substantial ( > 500 nucleotides) leader on RNA2 is similar to that of the coat proteins of other tobraviruses (13,22,42; figure 2 ). The size of this product is also similar to that of the coat protein of other tobraviruses (8, 13, 16, 22) and to that estimated for the PEBV(B)SP5 coat protein (13, 22, 42) . That this product is indeed the viral coat protein is demonstrated by the extensive homology it shows with those of PRV and the TRV strains PSG and TCM (figure 3). A computer database search for additional similar sequences revealed a significant homology between the tobraviral coat proteins and those of sunn hemp mosaic virus (43) and barley stripe mosaic virus (44) . These observations and their implications will be expanded upon elsewhere (in preparation).
The second ORF is separated from the coat protein ORF by 320 nucleotides. It starts with an AUG codon at nucleotides 1469-1471 and extends to a UAA codon at nucleotides 2234-2236 to encode a potential product of 255 A A residues with a mol. wt. of 29,559 (29.6K). This product is homologous to the 29. IK product specified by RNA2 from TRV(TCM). When identical residues are considered, the two products are 35 % homologous overall (figure 4). Although most such residues are N-terminal, the C-termini do include many conservative substitutions and the central region of both products (residues 100-150 of figure 4 ) has a periodicity of residues compatible with the formation of an extended a-helix. This conservation pattern implies that the exact characteristics of the conserved residues of the N-termini are required for the function of the products, whereas the less rigorously-conserved residues of the central region and C-termini fulfill more flexibly-specified roles in this function. The nature of this function is, however, unknown, and no similar proteins which might provide clues for its function were identified by a computer database search.
The third ORF is located just 31 nucleotides downstream of ORF2. Starting with an AUG codon at nucleotides 2268-2270 and extending to a UAA codon at nucleotides 2892-2894, ORF3 encodes a potential 208 AA residue product with a mol. wt. of 22,974 (23K). Although similar in size to tobraviral coat proteins, no homology between this product and any previously-described tobraviral (or other) protein was identified by a computer database search.
ORF 4 and noncoding sequences
In addition to the above ORFs, a small ORF potentially able to encode a 79 AA residue product with a mol. wt. of 9,047 (9K) is present in the region between ORFs 1 and 2. This ORF has, however, a number of features which combine to make its activity as an expressed ORF seem unlikely. It does not express the marked codon preference for U in the third codon position demonstrated by ORFs 1-3 and by all other tobraviral ORFs (not shown). Furthermore, when the RNA2 sequence was analysed by the computer method of Ficket (39, 45) , which makes use of statistical order present in coding sequences but absent from the less ordered noncoding sequences to make predictions about the nature of a sequence, only ORFs 1-3 were predicted (at 95% confidence) to be coding. The 5' leader, the ORF1/ORF2 intergenic sequence containing the small ORF and the 3' nontranslated region were all predicted (at 95 % confidence) to be noncoding. Assuming, therefore, that the small ORF is not expressed as a protein, but that the larger ORFs 1-3 are, the noncoding sequences of the RNA, consisting of the 5' 509 nucleotides, the intergenic regions of 320 and 30 nucleotides, and the 3' 480 nucleotides, totals 1340 nucleotides, or almost 40% of RNA2. This figure is comparable with those found for the RNA2 molecules of PRV and the TRV strains PLB, PSG and TCM, which respectively devote 63%, 52%, 67% and 47% of their length to noncoding sequences (8, 16, 21, 22) . The leader of PEBV(B)SP5 RNA2, like those of TRV RNA2 molecules, has no repeats similar to those which largely constitute the PRV RNA2 leader. The 3' terminal 43 nucleotides are compatible with the formation of a 14 base pair pseudoknot structure similar to that mapped to TRV (PSG) RNA (4). In addition, nucleotides located 47-71 and 84-128 from the 3' terminus are compatible with the formation of two large hairpin loops similar to those mapped to residues 45-71 and 83-128 from the 3' terminus of TRV(PSG)RNAs (4).
A putative subgenomic promoter has a conserved secondary structural element
The internal position of ORFs 1 -3 on RNA2 makes the use of subgenomic RNAs for their expression likely (46). Sequencing of subgenomic RNAs from TRV isolates has implicated the sequence GCAUA... in the generation of such messengers, which start with the underlined residue (16, 22) . This sequence is found upstream of all but one internal tobraviral ORFs described to date, including those of the PEBV RNA2 described here. In this case, it occurs within larger sequence contexts similar to those of other tobraviral RNAs from which subgenomic RNAs are known or proposed to be generated. Thus the sequence occurs (a) upstream of the 23K ORF within a nine nucleotide context precisely matching that found 24 nucleotides upstream of the 16K The underlined sequences of TRV strains TCM and PSG to the right of the bold residue indicate the extent to which the corresponding RNA2a molecules have been sequenced (16, 22) . Underlined sequences to the left of the bold residues are those potentially able to form stemloop structures on the minus strand. Within these regions, residues not underlined form single base bulges in the stem structures.
The numbers indicate the positions of the residue in bold in the corresponding RNA molecule.
ORF of TRV(PLB)(21), (b) upstream of the 29.6K ORF within an eight nucleotide context matching in six positions that identified upstream of the homologous TRV(TCM) ORF (22) , and (c) upstream of the coat protein ORF within a 16 nucleotide context precisely matching that identified upstream of the TRV(TCM) coat protein ORF (22) . Comparisons of the sequences upstream of the latter with the corresponding sequences from other tobraviral RNA2 sequences shows that all include inverted repeat sequences potentially able to form nine base pair stem structures with terminal loops of four nucleotides (figure 5a). In the PRV sequence, a mismatched base pair (C/A) exists. On the minus strand, however, from which subgenomic RNAs are likely to be synthesized by internal initiation (47), the complementary G/U residues would allow the formation of an uninterrupted nine base pair stemloop. A search for a similar association of potential secondary structure with the GCAUA... motif upstream of other tobraviral ORFs was, in general, not successful. However, similar potential structures having single base bulges were identified upstream of a number of PEBV ORFs (figure 5b). These potential structures may have a role in the generation of subgenomic RNAs.
DISCUSSION
With the presentation of the PEBV RNA2 sequence, complete nucleotide sequences are now available for this genomic component from representative members of all three tobraviral subgroups. Like other tobraviral RNA2 molecules (8, 16, 21, 22) , that of PEBV(B)SP5 makes peculiarly inefficient use of its length, only 60% of which is devoted to coding sequences. The 5' proximal ORF corresponds to the coat protein in which the genomic RNAs 1 and 2 are independently encapsidated. In this respect the RNA is like other tobraviral RNA2 molecules. The PEBV(B)SP5 coat protein shows homology with other tobraviral coat proteins ranging from 35% to 50% (figure 3). In reference to the diverse antigenic properties characteristic of tobraviral particles and the variable nucleic acid homologies displayed by the RNA2 molecules within the TRV subgroup, it has been suggested that the latter might not derive from a common ancestor (6) . Given the complete functional interchangeability of the coat protein-encoding RNA2 molecules within each subgroup (7, 25, 48) and the homology demonstrated here between the coat proteins of representative members of all three subgroups (figure 3), it now seems likely that at least the coat protein gene of all tobraviral RNA2 molecules may in fact derive from such an ancestor.
Previous reports show that the variability in length of RNA2 molecules is due to the presence of an ORF additional to coat protein on larger molecules and to a variable length of 3' terminal sequence 100% homologous to that of the corresponding RNA1 molecule (8, 16, 21, 22) . The PEBV(B)SP5 RNA2 sequence reveals two ORFs additional to coat protein and the shortest 3' terminal homology with RNA1 yet characterised among the tobraviruses. Unlike that of other sequenced tobraviruses, the 3' terminal homology between PEBV(B)SP5 RNAs is not absolute, but has nine differences in its 266 nucleotide length. It "has been suggested that maintenance, probably by recombination (21, 22) , of an absolute 3' terminal homology between RNAs 1 and 2 is important for their replication (21) . Nonetheless, heterologous pairing of TRV RNAs 1 and 2 with distinct 3' terminal sequences forms a stably-replicating pseudorecombinant virus which retains the terminal sequences of the parental molecules (22) . Thus maintenance or acquisition of identical 3' termini, at least for such pseudorecombinants in glasshouse conditions, is not a necessity. The data presented here show that this is also the case for PEBV(B)SP5, a natural field isolate. The nature of the selection pressures leading to perfect 3' terminal homologies between RNAs 1 and 2 of all other similarily-characterized field isolates has not been identified (22) .
It is not yet known whether the two additional ORFs encoding potential products of 29.6K and 23K are active. Analysis of the sequence by the method of Ficket (39, 45) , however, gave similar predictions for all three ORFs. Since the coat protein is known to be expressed (26) , it is reasonable to suppose that the two additional ORFs are also active. In addition, the homology between the 29.6K product and the TRV(TCM) 29. IK product implies that both are active ORFs. The internal position of the three ORFs on the RNA suggests the generation of subgenomic RNAs for their expression. Such RNAs are yet to be identified. Sequences closely similar to those including the GCAUA... subgenomic promoter motif (16) found upstream of other tobraviral ORFs known to be expressed from subgenomic RNAs were identified upstream of all three ORFs. The resultant putative subgenomic RNAs 2a, 2b and 2c would respectively allow the expression of the coat protein, the 29.6K and the 23K ORFs. RNA2 sequences upstream of those corresponding to RNA2a were found to be compatible with the formation of stemloop structures on the minus-strands of all five tobraviral RNA2 molecules sequenced to date (figure 5a). A search for similar structures associated with the GCAUA... motif elsewhere on tobraviral RNAs identified similar potential structures upstream of a number of PEBV ORFs (figure 5b) but suggested that stemloop structures were not a general feature of the sequences implicated in the generation of tobraviral subgenomic RNAs. The general absence of stemloop structures may be related to regulatory differences in the expression of the ORFs concerned. However, the association of such structures and the GCAUA... motif upstream of all five coat protein ORFs does appear to be significant on a number of grounds including (1) they are all identical in size, having 18 nucleotides participating in the stem and four in the terminal loop, (2) they all occur in exactly the same position relative to the GCAUA... motif and (3) they are all included among the most stable computer-generated secondary structures adopted by the minus strand (39, 49) . These structures are formed whether the analysis is performed with the 60 nucleotides upstream of the GCAUA... motif (figure 6) or with the 120 nucleotides flanking it (not shown). Similar combinations of stable hairpin structures and primary sequence motifs have been suggested to have a role in the generation of subgenomic RNAs from other plant viral RNAs (47, 50, 51) . In the case of the BMV RNA3 subgenomic promoter for the generation of RNA4, manipulations of infectious clones have confirmed the importance of the sequences which contribute in this way (51) . The availability of infectious clones for TRV RNAs 1 and 2 (19, 23) will allow the suggested significance of these potential structures for the tobraviral subgenomic promoter to be tested.
